NEW YORK--(BUSINESS WIRE)--Clinical AI-powered healthcare company K Health announced today a new collaboration with Mayo Clinic’s digital healthcare initiative, Mayo Clinic Platform, which harnesses ...

RADNOR, Pa., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney ...

Mineralys Therapeutics announced the positive results of its Launch-HTN trial, the largest study of an aldosterone synthase inhibitor for patients with uncontrolled or treatment-resistant hypertension ...

– Management to host virtual KOL event today to discuss the unmet need in hypertension, as well as a review of the ongoing pivotal clinical program for lorundrostat in hypertension – RADNOR, Pa., Oct.